Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Karnik

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cell|December 20, 2014
X chromosome reactivation dynamics reveal stages of reprogramming to pluripotencyVincent Pasque, Jason Tchieu, Rahul Karnik, et al.
Cell Reports|November 10, 2021
Chromatin-state barriers enforce an irreversible mammalian cell fate decisionM Andrés Blanco, David B Sykes, Lei Gu, et al.
Nature Genetics|January 24, 2018
Genetic determinants and epigenetic effects of pioneer-factor occupancyJulie Donaghey, Sudhir Thakurela, Jocelyn Charlton, et al.
Nature Genetics|March 31, 2015
Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cellsJing Liao, Rahul Karnik, Hongcang Gu, et al.
Nature|November 8, 2019
Author Correction: LKB1 loss links serine metabolism to DNA methylation and tumorigenesisFilippos Kottakis, Brandon N Nicolay, Ahlima Roumane, et al.
Nature|November 4, 2016
LKB1 loss links serine metabolism to DNA methylation and tumorigenesisFilippos Kottakis, Brandon N Nicolay, Ahlima Roumane, et al.
Cell|July 18, 2015
Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced PluripotencyDavide Cacchiarelli, Cole Trapnell, Michael J Ziller, et al.
Molecular Cancer Therapeutics|December 9, 2024
KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule InhibitorsYogesh K Chutake, Michele F Mayo, Nancy Dumont, et al.
Cell Reports|August 25, 2015
PRC2 Is Required to Maintain Expression of the Maternal Gtl2-Rian-Mirg Locus by Preventing De Novo DNA Methylation in Mouse Embryonic Stem CellsPartha Pratim Das, David A Hendrix, Effie Apostolou, et al.
Nature Medicine|November 13, 2023
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trialLindsay Ackerman, Gerard Acloque, Sandro Bacchelli, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell|December 20, 2014
X chromosome reactivation dynamics reveal stages of reprogramming to pluripotencyVincent Pasque, Jason Tchieu, Rahul Karnik, et al.
Cell Reports|November 10, 2021
Chromatin-state barriers enforce an irreversible mammalian cell fate decisionM Andrés Blanco, David B Sykes, Lei Gu, et al.
Nature Genetics|January 24, 2018
Genetic determinants and epigenetic effects of pioneer-factor occupancyJulie Donaghey, Sudhir Thakurela, Jocelyn Charlton, et al.
Nature Genetics|March 31, 2015
Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cellsJing Liao, Rahul Karnik, Hongcang Gu, et al.
Nature|November 8, 2019
Author Correction: LKB1 loss links serine metabolism to DNA methylation and tumorigenesisFilippos Kottakis, Brandon N Nicolay, Ahlima Roumane, et al.
Nature|November 4, 2016
LKB1 loss links serine metabolism to DNA methylation and tumorigenesisFilippos Kottakis, Brandon N Nicolay, Ahlima Roumane, et al.
Cell|July 18, 2015
Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced PluripotencyDavide Cacchiarelli, Cole Trapnell, Michael J Ziller, et al.
Molecular Cancer Therapeutics|December 9, 2024
KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule InhibitorsYogesh K Chutake, Michele F Mayo, Nancy Dumont, et al.
Cell Reports|August 25, 2015
PRC2 Is Required to Maintain Expression of the Maternal Gtl2-Rian-Mirg Locus by Preventing De Novo DNA Methylation in Mouse Embryonic Stem CellsPartha Pratim Das, David A Hendrix, Effie Apostolou, et al.
Nature Medicine|November 13, 2023
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trialLindsay Ackerman, Gerard Acloque, Sandro Bacchelli, et al.
Pageof 2